Tag: doses

Current COVID strain mild, SII producing 5-6million Covovax doses: Adar Poonawalla

[ad_1]
Pune: The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company’s chief executive officer Adar Poonawalla on Saturday.
Poonawalla was talking to media persons amid rising cases of coronavirus infections in the country since March.
India has recorded 12,193 fresh COVID-19 cases in a span of 24 hours, with the number of active cases of the infection going up to 67,556, the Union health ministry said on Saturday.

“Currently, the COVID strain is not severe, it’s just a mild strain. Just for precautionary measures, elderly people can get the booster dose, but it would be their choice whether or not to take it. Five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” said Poonawalla.
As per a health bulletin of the Maharashtra government on Friday, the XBB.1.16 variant of Omicron is currently the dominant strain in the state.
The Centre on Friday asked eight states, Uttar Pradesh, Tamil Nadu and Maharashtra, to maintain a strict watch and take preemptive action in any area of concern to control any emerging spread of infection.
“We are providing Covovax in the US and Europe. It is the only COVID vaccine made in India which is approved in the US and Europe. Currently, the demand is very small,” Poonawalla added.

[ad_2]
#Current #COVID #strain #mild #SII #producing #56million #Covovax #doses #Adar #Poonawalla
( With inputs from www.siasat.com )

April 22, 2023
Telangana starts administering booster doses of Covid vaccine

[ad_1]
Hyderabad: The Telangana government on Wednesday commenced administering booster doses as a precautionary measure in view of increase in Covid-19 cases.
The state government has arranged 5 lakh doses of Corbevax, manufactured by Hyderabad-based Biological E.
The state government has made all arrangements to administer the vaccines to all the eligible citizens at government Covid vaccine centres like primary health centres and urban primary health centres.

Director of Public Health and Family Welfare G. Srinivasa Rao said the doses have been arranged in view of the rise in Covid cases in many countries around the world as well in some states within the country.
Corbevax can be administered as a precautionary dose to those beneficiaries who have taken Covaxin or Covishield as first and second dose. The government of India has already approved Corbevax for heterologous administration.
The director of public health appealed to people to use this opportunity and ensure that all the left out
The state government had last month written to the Union Ministry of Health and Family Welfare to provide additional Covid booster shots for the state. However, with the Centre asking the states to directly procure Covid vaccines and booster shots from the open market, the Telangana government had decided to procure 15 lakh does from Hyderabad-based Biological E to resume vaccination.
Telangana is witnessing an increase in Covid cases for the last few days. The daily count has almost doubled in the last one week.

On Tuesday, the state recorded 52 cases, up from 41 the previous day. The number of active cases has also gone up from 269 to 281.
Hyderabad logged 21 new Covid cases on Tuesday. The state’s Covid recovery rate remained at 99.48 per cent.
[ad_2]
#Telangana #starts #administering #booster #doses #Covid #vaccine
( With inputs from www.siasat.com )

April 19, 2023
3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech’s Krishna Ella

[ad_1]
New Delhi: Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company’s executive chairman Krishna Ella said on Sunday.
He was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madison Global Health Institute (GHI) and the Ella Foundation for the establishment of the first-ever UW-Madison One Health Centre in Bengaluru.
iNCOVACC, the world’s first intranasal COVID-19 vaccine, was launched on January 26. The vaccine is now available on CoWIN and priced at Rs 800 for private markets and Rs 325 for the government of India and state governments.
“We dispatched three lakh doses of the world’s first intranasal COVID-19 vaccine to some hospitals two days ago,” Ella said.
On whether Bharat Biotech is looking at exporting the vaccine, he said some countries and international agencies are approaching the company for the intra-nasal vaccine.
Innova is also the world’s first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose for adults.
Ella said the UW-Madison One Health Centre in Bengaluru is expected to be operational by the end of 2023.
It will advance the development and production of new vaccines for India. Furthermore, the partnership will enable collaboration across disciplines and geographic boundaries, provide Indian students and researchers access to UW expertise and training, and build research capacity in India, he said.

“Both Ella Foundation and UW-Madison GHI share a common vision to advance innovation in science, research, and knowledge sharing. Establishing the UW-Madison Global One Health Centre holds great significance as it will advance global health through research, education, and community engagement by facilitating student, and faculty exchanges, research and education,” he added.
UW-Madison GHI director Jorge Osorio said, “We are energised by the opportunity to partner with the Ella Foundation to bring UW knowledge and expertise to expand innovative and impactful health initiatives outside Wisconsin to India.”
The India One Health Centre joins a global network that includes Africa and Latin America and will open new opportunities for research, education, and provide actionable outcomes to benefit humans, animals, and ecosystems that advance equitable and sustainable health across India and the world.
[ad_2]
#lakh #doses #intranasal #Covid #vaccine #hospitals #Bharat #Biotechs #Krishna #Ella
( With inputs from www.siasat.com )

February 5, 2023